Eileen Dareng, MD, PhD

Director Safety Epidemiology
Astra Zeneca, United Kingdom

Poster(s):

• (325) Use of population-based real world data sources and disease specific registries to conduct post approval pregnancy safety studies for a biologic indicated for a complex, uncommon indication - challenges and opportunities
  Tuesday, August 27, 2024

  8:00 AM – 6:00 PM CEST